Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Meunier, L; Monsigny, M; Roche, AC
   Propynylated phosphodiester oligonucleotides inhibit ICAM-1 expression in A549 cells on electroporation
   ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
   
   L. Meunier et al., "Propynylated phosphodiester oligonucleotides inhibit ICAM-1 expression in A549 cells on electroporation", ANTISENSE N, 11(2), 2001, pp. 117-123
2. Ino, H; Chiba, T
   Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo
   JOURNAL OF NEUROSCIENCE
   
   H. Ino e T. Chiba, "Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo", J NEUROSC, 21(16), 2001, pp. 6086-6094
3. Joyce, GF
   RNA cleavage by the 10-23 DNA enzyme
   RIBONUCLEASES, PT A
   
   G.F. Joyce, "RNA cleavage by the 10-23 DNA enzyme", METH ENZYM, 341, 2001, pp. 503-517
4. Grillone, LR; Lanz, R
   Fomivirsen
   DRUGS OF TODAY
   
   L.R. Grillone e R. Lanz, "Fomivirsen", DRUGS TODAY, 37(4), 2001, pp. 245-255
5. Cantz, T; Ott, M; Kubicka, S; Manns, MP
   Gene therapy and immunotherapy for liver diseases
   INTERNIST
   
   T. Cantz et al., "Gene therapy and immunotherapy for liver diseases", INTERNIST, 42(10), 2001, pp. 1357
6. Mishra, M; Porter-Kelley, JM; Singh, PK; Bennett, JR; Chaudhuri, G
   Enhanced activity of antisense phosphorothioate oligos against Leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions
   BIOCHEMICAL PHARMACOLOGY
   
   M. Mishra et al., "Enhanced activity of antisense phosphorothioate oligos against Leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions", BIOCH PHARM, 62(5), 2001, pp. 569-580
7. Mishra, M; Bennett, JR; Chaudhuri, G
   Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H
   BIOCHEMICAL PHARMACOLOGY
   
   M. Mishra et al., "Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H", BIOCH PHARM, 61(4), 2001, pp. 467-476
8. Fillion, P; Desjardins, A; Sayasith, K; Lagace, J
   Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides
   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
   
   P. Fillion et al., "Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides", BBA-BIOMEMB, 1515(1), 2001, pp. 44-54
9. Dymock, BW; Jones, PS; Wilson, FX
   Novel approaches to the treatment of hepatitis C virus infection
   ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
   
   B.W. Dymock et al., "Novel approaches to the treatment of hepatitis C virus infection", ANTIVIR CHE, 11(2), 2000, pp. 79-96
10. Branch, AD
    Hepatitis C virus RNA codes for proteins and replicates: Does it also trigger the interferon response?
    SEMINARS IN LIVER DISEASE
    
    A.D. Branch, "Hepatitis C virus RNA codes for proteins and replicates: Does it also trigger the interferon response?", SEM LIV DIS, 20(1), 2000, pp. 57-68
11. Efferth, T; Fabry, U; Osieka, R
    Leptin contributes to the protection of human leukemic cells from cisplatinum cytoxicity
    ANTICANCER RESEARCH
    
    T. Efferth et al., "Leptin contributes to the protection of human leukemic cells from cisplatinum cytoxicity", ANTICANC R, 20(4), 2000, pp. 2541-2546
12. Giles, RV; Spiller, DG; Tidd, DM
    Chimeric oligodeoxynucleotide analogs: Chemical synthesis, purification, and molecular and cellular biology protocols
    ANTISENSE TECHNOLOGY, PT A
    
    R.V. Giles et al., "Chimeric oligodeoxynucleotide analogs: Chemical synthesis, purification, and molecular and cellular biology protocols", METH ENZYM, 313, 2000, pp. 95-135
13. Souvignet, C; Zarski, JP
    Gene therapy approaches in chronic viral hepatitis
    THERAPIE
    
    C. Souvignet e J.P. Zarski, "Gene therapy approaches in chronic viral hepatitis", THERAPIE, 55(3), 2000, pp. 333-341
14. Atkins, D; Miller, M; De Bouvere, B; van Aerschot, A; Herdewijn, P
    Evaluation of the cellular uptake of hexitol nucleic acids in HeLa cells
    PHARMAZIE
    
    D. Atkins et al., "Evaluation of the cellular uptake of hexitol nucleic acids in HeLa cells", PHARMAZIE, 55(8), 2000, pp. 615-617
15. Toyoda, T; Imamura, Y; Takaku, H; Kashiwagi, T; Hara, K; Iwahashi, J; Ohtsu, Y; Tsumura, N; Kato, H; Hamada, N
    Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme
    FEBS LETTERS
    
    T. Toyoda et al., "Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme", FEBS LETTER, 481(2), 2000, pp. 113-116
16. Walker, MA
    Hepatitis C virus: an overview of current approaches and progress
    DRUG DISCOVERY TODAY
    
    M.A. Walker, "Hepatitis C virus: an overview of current approaches and progress", DRUG DISC T, 4(11), 1999, pp. 518-529
17. Ruiz, J; Qian, C; Drozdzik, M; Prieto, J
    Gene therapy of viral hepatitis and hepatocellular carcinoma
    JOURNAL OF VIRAL HEPATITIS
    
    J. Ruiz et al., "Gene therapy of viral hepatitis and hepatocellular carcinoma", J VIRAL HEP, 6(1), 1999, pp. 17-34
18. Watanabe, N; Sawai, H; Endo, K; Shinozuka, K; Ozaki, H; Tanada, S; Murata, H; Sasaki, Y
    Labeling of phosphorothioate antisense oligonucleotides with yttrium-90
    NUCLEAR MEDICINE AND BIOLOGY
    
    N. Watanabe et al., "Labeling of phosphorothioate antisense oligonucleotides with yttrium-90", NUCL MED BI, 26(2), 1999, pp. 239-243
19. Maurer, N; Mori, A; Palmer, L; Monck, MA; Mok, KWC; Mui, B; Akhong, QF; Cullis, PR
    Lipid-based systems for the intracellular delivery of genetic drugs
    MOLECULAR MEMBRANE BIOLOGY
    
    N. Maurer et al., "Lipid-based systems for the intracellular delivery of genetic drugs", MOL MEMBR B, 16(1), 1999, pp. 129-140
20. Blum, HE
    Molecular biology and gene therapy in gastroenterology and hepatology
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    H.E. Blum, "Molecular biology and gene therapy in gastroenterology and hepatology", EUR J GASTR, 11(1), 1999, pp. 1-7
21. Yu, RZ; Geary, RS; Leeds, JM; Watanabe, T; Fitchett, JR; Matson, JE; Mehta, R; Hardee, GR; Templin, MV; Huang, K; Newman, MS; Quinn, Y; Uster, P; Zhu, G; Working, PK; Horner, M; Nelson, J; Levin, AA
    Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-ras encapsulated in stealth liposomes
    PHARMACEUTICAL RESEARCH
    
    R.Z. Yu et al., "Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-ras encapsulated in stealth liposomes", PHARM RES, 16(8), 1999, pp. 1309-1315
22. Laktionov, PP; Dazard, JE; Vives, E; Rykova, EY; Piette, J; Vlassov, VV; Lebleu, B
    Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes
    NUCLEIC ACIDS RESEARCH
    
    P.P. Laktionov et al., "Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes", NUCL ACID R, 27(11), 1999, pp. 2315-2324
23. Chao, Y; Shih, YL; Chen, HJ; Lee, SD; Huang, TS
    Inhibition of DNA synthesis by downregulation of cyclin A but not Skp 2 overexpression in human hepatocellular carcinoma cells
    CANCER LETTERS
    
    Y. Chao et al., "Inhibition of DNA synthesis by downregulation of cyclin A but not Skp 2 overexpression in human hepatocellular carcinoma cells", CANCER LETT, 139(1), 1999, pp. 1-6
24. Chen, SH; Tzeng, RT
    Polymer solution-filled column for the analysis of antisense phosphorothioates by capillary electrophoresis
    ELECTROPHORESIS
    
    S.H. Chen e R.T. Tzeng, "Polymer solution-filled column for the analysis of antisense phosphorothioates by capillary electrophoresis", ELECTROPHOR, 20(3), 1999, pp. 547-554
25. Wagner, H
    Bacterial CpG DNA activates immune cells to signal infectious danger
    ADVANCES IN IMMUNOLOGY, VOL 73
    
    H. Wagner, "Bacterial CpG DNA activates immune cells to signal infectious danger", ADV IMMUNOL, 73, 1999, pp. 329-368
26. Liang, E; Ajmani, PS; Hughes, JA
    Oligonucleotide delivery: a cellular prospective
    PHARMAZIE
    
    E. Liang et al., "Oligonucleotide delivery: a cellular prospective", PHARMAZIE, 54(8), 1999, pp. 559-566
27. Tao, M; Miyano-Kurosaki, N; Takai, K; Takaku, H
    Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells
    FEBS LETTERS
    
    M. Tao et al., "Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells", FEBS LETTER, 454(3), 1999, pp. 312-316
28. Kaufman, GD; Shinder, ME; Perachio, AA
    Correlation of Fos expression and circling asymmetry during gerbil Vestibular compensation
    BRAIN RESEARCH
    
    G.D. Kaufman et al., "Correlation of Fos expression and circling asymmetry during gerbil Vestibular compensation", BRAIN RES, 817(1-2), 1999, pp. 246-255
29. NARUSE K; YAMADA T; SAI XR; HAMAGUCHI M; SOKABE M
    PP125(FAK) IS REQUIRED FOR STRETCH DEPENDENT MORPHOLOGICAL RESPONSE OF ENDOTHELIAL-CELLS
    Oncogene
    
    K. Naruse et al., "PP125(FAK) IS REQUIRED FOR STRETCH DEPENDENT MORPHOLOGICAL RESPONSE OF ENDOTHELIAL-CELLS", Oncogene, 17(4), 1998, pp. 455-463
30. BORAL AL; DESSAIN S; CHABNER BA
    CLINICAL-EVALUATION OF BIOLOGICALLY TARGETED DRUGS - OBSTACLES AND OPPORTUNITIES
    Cancer chemotherapy and pharmacology
    
    A.L. Boral et al., "CLINICAL-EVALUATION OF BIOLOGICALLY TARGETED DRUGS - OBSTACLES AND OPPORTUNITIES", Cancer chemotherapy and pharmacology, 42, 1998, pp. 3-21
31. SOKOLOSKI JA; NARAYANAN R; SARTORELLI AC
    ENHANCEMENT BY ANTISENSE OLIGONUCLEOTIDES TO NF-KB OF THE DIFFERENTIATION OF HL-60 PROMYELOCYTIC LEUKEMIA-CELLS INDUCED BY VITAMIN-D-3
    Cancer letters
    
    J.A. Sokoloski et al., "ENHANCEMENT BY ANTISENSE OLIGONUCLEOTIDES TO NF-KB OF THE DIFFERENTIATION OF HL-60 PROMYELOCYTIC LEUKEMIA-CELLS INDUCED BY VITAMIN-D-3", Cancer letters, 125(1-2), 1998, pp. 157-164
32. Wedemeyer, H; Caselmann, WH; Manns, MP
    Combination therapy of chronic hepatitis C: an important step but not the final goal!
    JOURNAL OF HEPATOLOGY
    
    H. Wedemeyer et al., "Combination therapy of chronic hepatitis C: an important step but not the final goal!", J HEPATOL, 29(6), 1998, pp. 1010-1014
33. THOMPSON EB
    THE MANY ROLES OF C-MYC IN APOPTOSIS
    Annual review of physiology
    
    E.B. Thompson, "THE MANY ROLES OF C-MYC IN APOPTOSIS", Annual review of physiology, 60, 1998, pp. 575-600
34. ALAHARI SK; DELONG R; FISHER MH; DEAN NM; VILIET P; JULIANO RL
    NOVEL CHEMICALLY-MODIFIED OLIGONUCLEOTIDES PROVIDE POTENT INHIBITION OF P-GLYCOPROTEIN EXPRESSION
    The Journal of pharmacology and experimental therapeutics
    
    S.K. Alahari et al., "NOVEL CHEMICALLY-MODIFIED OLIGONUCLEOTIDES PROVIDE POTENT INHIBITION OF P-GLYCOPROTEIN EXPRESSION", The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 419-428
35. BRAND RM; WAHL A; IVERSEN PL
    EFFECTS OF SIZE AND SEQUENCE ON THE IONTOPHORETIC DELIVERY OF OLIGONUCLEOTIDES
    Journal of pharmaceutical sciences
    
    R.M. Brand et al., "EFFECTS OF SIZE AND SEQUENCE ON THE IONTOPHORETIC DELIVERY OF OLIGONUCLEOTIDES", Journal of pharmaceutical sciences, 87(1), 1998, pp. 49-52
36. KRONENWETT R; STEIDL U; KIRSCH M; SCZAKIEL G; HAAS R
    OLIGODEOXYRIBONUCLEOTIDE UPTAKE IN PRIMARY HUMAN HEMATOPOIETIC-CELLS IS ENHANCED BY CATIONIC LIPIDS AND DEPENDS ON THE HEMATOPOIETIC-CELL SUBSET
    Blood
    
    R. Kronenwett et al., "OLIGODEOXYRIBONUCLEOTIDE UPTAKE IN PRIMARY HUMAN HEMATOPOIETIC-CELLS IS ENHANCED BY CATIONIC LIPIDS AND DEPENDS ON THE HEMATOPOIETIC-CELL SUBSET", Blood, 91(3), 1998, pp. 852-862
37. ANAZODO MI; DUTA E; SALOMON H; FRIESEN AD; WAINBERG MA; WRIGHT JA
    CHARACTERIZATION OF GPI2A, A POTENT INHIBITOR OF HIV-1 GENE-EXPRESSION AND VIRAL REPLICATION
    Nucleosides & nucleotides
    
    M.I. Anazodo et al., "CHARACTERIZATION OF GPI2A, A POTENT INHIBITOR OF HIV-1 GENE-EXPRESSION AND VIRAL REPLICATION", Nucleosides & nucleotides, 16(7-9), 1997, pp. 1241-1249
38. ENJOLRAS N; GODINOT C
    INHIBITION OF UBIQUITOUS MITOCHONDRIAL CREATINE-KINASE EXPRESSION IN HELA-CELLS BY AN ANTISENSE OLIGODEOXYNUCLEOTIDE
    Molecular and cellular biochemistry
    
    N. Enjolras e C. Godinot, "INHIBITION OF UBIQUITOUS MITOCHONDRIAL CREATINE-KINASE EXPRESSION IN HELA-CELLS BY AN ANTISENSE OLIGODEOXYNUCLEOTIDE", Molecular and cellular biochemistry, 167(1-2), 1997, pp. 113-125
39. ZABNER J
    CATIONIC LIPIDS USED IN GENE-TRANSFER
    Advanced drug delivery reviews
    
    J. Zabner, "CATIONIC LIPIDS USED IN GENE-TRANSFER", Advanced drug delivery reviews, 27(1), 1997, pp. 17-28
40. CHRISTOFIDOUSOLOMIDOU M; ALBELDA SM; BENNETT FC; MURPHY GF
    EXPERIMENTAL PRODUCTION AND MODULATION OF HUMAN CYTOTOXIC DERMATITIS IN HUMAN-MURINE CHIMERAS
    The American journal of pathology
    
    M. Christofidousolomidou et al., "EXPERIMENTAL PRODUCTION AND MODULATION OF HUMAN CYTOTOXIC DERMATITIS IN HUMAN-MURINE CHIMERAS", The American journal of pathology, 150(2), 1997, pp. 631-639
41. GIACHETTI C; CHIN DJ
    INCREASED OLIGONUCLEOTIDE PERMEABILITY IN KERATINOCYTES OF ARTIFICIALSKIN CORRELATES IN DIFFERENTIATION AND ALTERED MEMBRANE-FUNCTION (VOL106, PG 412, 1996)
    Journal of investigative dermatology
    
    C. Giachetti e D.J. Chin, "INCREASED OLIGONUCLEOTIDE PERMEABILITY IN KERATINOCYTES OF ARTIFICIALSKIN CORRELATES IN DIFFERENTIATION AND ALTERED MEMBRANE-FUNCTION (VOL106, PG 412, 1996)", Journal of investigative dermatology, 107(2), 1996, pp. 255-262
42. TOLOU H; PUGGELLI H; TOCK F; DURAND JP
    PARTIAL INHIBITION OF YELLOW-FEVER VIRUS-REPLICATION IN-VITRO WITH DIFFERENT PHOSPHOROTHIOATE OLIGODEOXYRIBONUCLEOTIDE
    Acta virologica
    
    H. Tolou et al., "PARTIAL INHIBITION OF YELLOW-FEVER VIRUS-REPLICATION IN-VITRO WITH DIFFERENT PHOSPHOROTHIOATE OLIGODEOXYRIBONUCLEOTIDE", Acta virologica, 40(2), 1996, pp. 73-79
43. SAKAKURA C; HAGIWARA A; TSUJIMOTO H; OZAKI K; SAKAKIBARA T; OYAMA T; OGAKI M; IMANISHI T; YAMAZAKI J; TAKAHASHI T
    INHIBITION OF COLON-CANCER CELL-PROLIFERATION BY ANTISENSE OLIGONUCLEOTIDES TARGETING THE MESSENGER-RNA OF THE KI-RAS GENE
    Anti-cancer drugs
    
    C. Sakakura et al., "INHIBITION OF COLON-CANCER CELL-PROLIFERATION BY ANTISENSE OLIGONUCLEOTIDES TARGETING THE MESSENGER-RNA OF THE KI-RAS GENE", Anti-cancer drugs, 6(4), 1995, pp. 553-561
44. ZHANG RW; LU ZH; ZHAO H; ZHANG XS; DIASIO RB; HABUS I; JIANG ZW; IYER RP; YU D; AGRAWAL S
    IN-VIVO STABILITY, DISPOSITION AND METABOLISM OF A HYBRID OLIGONUCLEOTIDE PHOSPHOROTHIOATE IN RATS
    Biochemical pharmacology
    
    R.W. Zhang et al., "IN-VIVO STABILITY, DISPOSITION AND METABOLISM OF A HYBRID OLIGONUCLEOTIDE PHOSPHOROTHIOATE IN RATS", Biochemical pharmacology, 50(4), 1995, pp. 545-556
45. ZHANG RW; DIASIO RB; LU ZH; LIU TP; JIANG ZW; GALBRAITH WM; AGRAWAL S
    PHARMACOKINETICS AND TISSUE DISTRIBUTION IN RATS OF AN OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) DEVELOPED AS A THERAPEUTIC AGENT FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    Biochemical pharmacology
    
    R.W. Zhang et al., "PHARMACOKINETICS AND TISSUE DISTRIBUTION IN RATS OF AN OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) DEVELOPED AS A THERAPEUTIC AGENT FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1", Biochemical pharmacology, 49(7), 1995, pp. 929-939
46. GILLARDON F; BECK H; UHLMANN E; HERDEGEN T; SANDKUHLER J; PEYMAN A; ZIMMERMANN M
    INHIBITION OF A C-FOS PROTEIN EXPRESSION IN RAT SPINAL-CORD BY ANTISENSE OLIGODEOXYNUCLEOTIDE SUPERFUSION
    European journal of neuroscience
    
    F. Gillardon et al., "INHIBITION OF A C-FOS PROTEIN EXPRESSION IN RAT SPINAL-CORD BY ANTISENSE OLIGODEOXYNUCLEOTIDE SUPERFUSION", European journal of neuroscience, 6(5), 1994, pp. 880-884
47. SCHLINGENSIEPEN KH; SCHLINGENSIEPEN R; KUNST M; KLINGER I; GERDES W; SEIFERT W; BRYSCH W
    OPPOSITE FUNCTIONS OF JUN-B AND C-JUN IN GROWTH-REGULATION AND NEURONAL DIFFERENTIATION
    Developmental genetics
    
    K.H. Schlingensiepen et al., "OPPOSITE FUNCTIONS OF JUN-B AND C-JUN IN GROWTH-REGULATION AND NEURONAL DIFFERENTIATION", Developmental genetics, 14(4), 1993, pp. 305-312